Colgate-Palmolive Company
(NYSE: CL)Share Price and News
About Colgate
Colgate-Palmolive is a multinational consumer products company with a core focus on oral hygiene, personal care, and household cleaning. Headquartered in the United States, the company operates in over 200 countries, including significant markets across Asia, Latin America, and Europe.
Colgate's product range includes well-known brands such as Colgate toothpaste, Palmolive soaps, and Softsoap, alongside pet nutrition products under the Hill's brand.
The company's ability to innovate within its categories, such as developing toothpaste with natural ingredients or eco-friendly packaging, has helped it retain customer loyalty and adapt to changing consumer preferences.
Colgate's scale and global distribution network provide a competitive advantage, enabling it to penetrate diverse markets effectively while maintaining consistent product availability and quality.
Colgate's Company History
Colgate's origins date back to 1806 when William Colgate founded a starch, soap, and candle business on Dutch Street in New York City. He ran the company until his death in 1857 when his son Samuel took over.
The company quickly grew, introducing toothpaste in the late 19th century and expanding its product line over the decades. By 1906, it had over 800 different products.
A pivotal moment came in 1928 with the merger of Colgate & Company and Palmolive-Peet, creating the modern Colgate-Palmolive. Palmolive traces its origins to 1864 when B.J. Johnson opened a soap factory in Wisconsin. The company listed on the NYSE in 1930.
Since then, the company has expanded through acquisitions, including the purchase of Hill's Pet Nutrition in 1976, which broadened its footprint in the lucrative pet care market. It has also introduced 'home grown' products including the Ajax cleaner in 1947 and Palmolive dishwashing liquid in 1966. In recent years, it has expanded into professional skic care, buying PCA Skin and EltaMD in 2018.
Colgate has been paying dividends to shareholders for 128 years and has raised dividends consistently for the past 60 years. It has returned US$28bn to shareholders, through dividends and stock buybacks, over the last decade.
Future Outlook of Colgate (NYSE: CL)
The future outlook for Colgate‑Palmolive reflects a mix of steady growth expectations and strategic transformation aimed at driving longer‑term consumer engagement. The company reported strong Q4 2025 earnings, beating analyst forecasts on both revenue and earnings per share — outcomes that helped reaffirm confidence in its business model.
For 2026, Colgate has guided to net sales growth of approximately 2 % to 6 %, with organic sales growth on the order of 1 % to 4 %, and adjusted earnings per share expected to grow in the low‑to‑mid single digits. Management also anticipates improved gross profit margins and continued support for marketing and innovation programs to strengthen its brands globally.
There are strategic initiatives underway, including a 2030 growth strategy focused on expanding digital channels, optimising the supply chain and accelerating product innovation. These plans aim to enhance Colgate’s reach in emerging markets and capture incremental share in core categories, especially oral care, where the brand holds significant market leadership.
That said, the company operates in a highly competitive consumer staples environment where volume growth can be pressured by economic conditions and price‑sensitive consumers, particularly in developed markets. Foreign exchange fluctuations and raw material headwinds — including tariffs — have also posed challenges recently, although management has adjusted pricing and operational responses accordingly.
Overall, Colgate’s outlook combines modest top‑line momentum with long‑term brand and operational investments, characteristic of a mature global consumer goods leader.
Is Colgate a Good Stock to Buy?
Colgate‑Palmolive is often considered a classic defensive consumer stock, attracting investors seeking stability, steady cash flow and reliable dividends. The company’s products — from toothpaste to personal and home care items — are everyday essentials that tend to maintain demand even in turbulent economic environments. Its long record of dividend payments and increases underscores its reputation as a shareholder‑friendly company.
Analyst sentiment toward CL shares tends to be broadly positive. Recent consensus ratings, based on multiple brokerages, have leaned toward “Moderate Buy” or Hold, with price targets reflecting modest upside potential versus the current stock price. Some analysts cite Colgate’s market share, global distribution capabilities and brand strength as core advantages.
Despite this, the company is not immune to sector headwinds. Organic sales growth has moderated compared with previous years, and there are ongoing macroeconomic pressures that can influence consumer behaviour. Raw material cost increases and foreign exchange volatility have required pricing adjustments and operational responses.
Valuation is another important consideration. Colgate stocks often trade at relatively stable multiples reflective of their defensive status, with investors paying a premium for predictability rather than explosive growth. Returns are typically driven by dividends and moderate earnings expansion rather than rapid share‑price appreciation.
All up, Colgate‑Palmolive may appeal to investors seeking stable income, modest growth and exposure to a globally entrenched consumer goods brand, though it likely suits those with a long‑term, conservative investment horizon rather than traders seeking high short‑term returns.
Our Stock Analysis
How exactly do high interest rates impact tech stocks? Here are 6 ways
We all know high interest rates impact tech stocks – yesterday’s hike by the RBA led to the ASX 200’s…
Colgate (NYSE:CL): There’s more to it than toothpaste – it could be the best way to profit from the growth in pet products!
In Australia, we know Colgate (NYSE:CL) primarily as a toothpaste brand. But there’s a lot more to this 217-year old…
Here are the 6 Best American stocks for Australian investors in 2025!
Here are the 6 Best American stocks for Australian investors in 2025! Eli Lilly (NYSE:ELY) If you thought Novo Nordisk’s…
Frequently Asked Questions
Colgate typically offers a dividend yield around 2-3%, backed by strong cash flows and a track record of dividend increases spanning several decades.